| Primary |
| Pyrexia |
16.4% |
| Pharyngolaryngeal Pain |
9.8% |
| Drug Abuse |
8.2% |
| Pharyngitis |
8.2% |
| Product Used For Unknown Indication |
6.6% |
| Stomach Discomfort |
6.6% |
| Upper Respiratory Tract Infection |
6.6% |
| Basedow's Disease |
4.9% |
| Odynophagia |
4.9% |
| Furuncle |
3.3% |
| Infection |
3.3% |
| Prophylaxis |
3.3% |
| Sinusitis |
3.3% |
| Skin Infection |
3.3% |
| Skin Test Positive |
3.3% |
| Aspiration Joint |
1.6% |
| Asthenia |
1.6% |
| Atrial Fibrillation |
1.6% |
| Bronchitis |
1.6% |
| Cellulitis |
1.6% |
|
| Rash |
11.1% |
| Acute Generalised Exanthematous Pustulosis |
7.4% |
| Angioedema |
7.4% |
| Drug Hypersensitivity |
7.4% |
| Paraesthesia |
7.4% |
| Tooth Discolouration |
7.4% |
| Blood Alkaline Phosphatase Increased |
3.7% |
| Breast Swelling |
3.7% |
| Bronchospasm |
3.7% |
| Drug Abuse |
3.7% |
| Fear |
3.7% |
| Foetal Exposure During Pregnancy |
3.7% |
| Grand Mal Convulsion |
3.7% |
| Hepatitis |
3.7% |
| Infection |
3.7% |
| Malaise |
3.7% |
| Movement Disorder |
3.7% |
| Ocular Hyperaemia |
3.7% |
| Pharyngolaryngeal Pain |
3.7% |
| Pruritus |
3.7% |
|
| Secondary |
| Asthenia |
13.2% |
| Dysphagia |
13.2% |
| Odynophagia |
13.2% |
| Product Used For Unknown Indication |
12.9% |
| Drug Use For Unknown Indication |
10.0% |
| Pyrexia |
9.7% |
| Pain |
4.1% |
| Pharyngitis |
3.1% |
| Prophylaxis |
2.8% |
| Stomach Discomfort |
2.5% |
| Nasopharyngitis |
2.2% |
| Fasciitis |
1.9% |
| Hypertension |
1.9% |
| Pharyngolaryngeal Pain |
1.9% |
| Diabetes Mellitus |
1.6% |
| Atrial Fibrillation |
1.3% |
| Basedow's Disease |
1.3% |
| Ill-defined Disorder |
1.3% |
| Thrombosis Prophylaxis |
1.3% |
| Antibiotic Prophylaxis |
0.9% |
|
| Toxic Epidermal Necrolysis |
43.3% |
| Drug Hypersensitivity |
8.3% |
| Thrombocytopenia |
6.7% |
| Urticaria |
5.0% |
| Paraesthesia |
3.3% |
| Rash |
3.3% |
| Respiratory Arrest |
3.3% |
| Strabismus Congenital |
3.3% |
| Vomiting |
3.3% |
| White Blood Cell Count Increased |
3.3% |
| Adverse Drug Reaction |
1.7% |
| Cardio-respiratory Arrest |
1.7% |
| Chills |
1.7% |
| Drug Eruption |
1.7% |
| Hepatitis |
1.7% |
| Hypersensitivity |
1.7% |
| Liver Function Test Abnormal |
1.7% |
| Liver Injury |
1.7% |
| Liver Transplant |
1.7% |
| Medication Error |
1.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.2% |
| Product Used For Unknown Indication |
15.0% |
| Pain |
11.1% |
| Nausea |
6.4% |
| Arthritis |
4.1% |
| Cardiac Disorder |
3.9% |
| Muscle Spasms |
3.8% |
| Hypercalcaemia |
3.5% |
| Gastrooesophageal Reflux Disease |
3.4% |
| Hypertension |
3.4% |
| Depression |
3.3% |
| Sleep Disorder |
3.0% |
| Contraception |
2.8% |
| Oral Contraception |
2.8% |
| Eczema |
2.5% |
| Insomnia |
2.5% |
| Prostate Cancer |
2.5% |
| Abdominal Pain Upper |
2.1% |
| Oral Disorder |
2.0% |
| Acne |
1.9% |
|
| Urinary Tract Infection |
9.8% |
| Narcolepsy |
8.9% |
| Weight Decreased |
8.9% |
| Vomiting |
7.3% |
| Tremor |
6.5% |
| Anxiety |
5.7% |
| Swelling |
5.7% |
| Tooth Extraction |
4.9% |
| Wound Secretion |
4.9% |
| Blood Amylase Increased |
4.1% |
| Sweat Gland Infection |
4.1% |
| Thrombocytopenia |
4.1% |
| Weight Increased |
4.1% |
| Drug Exposure During Pregnancy |
3.3% |
| Pain |
3.3% |
| Respiratory Rate Decreased |
3.3% |
| Unevaluable Event |
3.3% |
| Upper Limb Fracture |
3.3% |
| Amnesia |
2.4% |
| Chest Pain |
2.4% |
|
| Interacting |
| Cough |
60.0% |
| Asthma |
20.0% |
| Contraception |
20.0% |
|
|
